SOCIOECONOMIC VALUE OF OCRELIZUMAB IN THE TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS

被引：0
|
作者：
Di Maio, D. [1 ]
Liu, C. [1 ]
Marcelli, G. [1 ]
Alvarez, Sanchez J. [1 ]
Overell, J. [1 ]
机构：
[1] F Hoffman La Roche Ltd, Basel, Switzerland
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND47
引用
收藏
页码：S631 / S631
页数：1
相关论文
共 50 条
  • [21] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
  • [22] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Kadner, Karen
    Pradhan, Ashish
    Incera, Elodie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
  • [23] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Craveiro, L.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306
  • [24] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Kadner, K.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 354 - 355
  • [25] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Prajapati, K.
    Koendgen, H.
    Craveiro, L.
    Hughes, R.
    Pradhan, A.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 68 - 69
  • [26] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 334 - 334
  • [27] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Hughes, Richard
    McNamara, John
    Pradhan, Ashish
    Wormser, David
    Koendgen, Harold
    Wolinsky, Jerry S.
    NEUROLOGY, 2019, 92 (15)
  • [28] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    Koendgen, H.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
  • [29] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
  • [30] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Kappos, Ludwig
    Hauser, Stephen
    Montalban, Xavier
    Buffels, Regine
    Chin, Peter
    Li, Carrie
    Mortensen, Deborah
    Napieralski, Julie
    Van Beek, Johan
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
12345